Maravai Lifesciences Stock Forward View - Simple Moving Average
| MRVI Stock | USD 3.26 0.11 3.26% |
Maravai Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Maravai Lifesciences' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 4th of February 2026, the relative strength index (RSI) of Maravai Lifesciences' share price is approaching 45. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Maravai Lifesciences, making its price go up or down. Momentum 45
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.33) | EPS Estimate Next Quarter (0.07) | EPS Estimate Current Year (0.31) | EPS Estimate Next Year (0.21) | Wall Street Target Price 3.9286 |
Using Maravai Lifesciences hype-based prediction, you can estimate the value of Maravai Lifesciences Holdings from the perspective of Maravai Lifesciences response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Maravai Lifesciences using Maravai Lifesciences' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Maravai using crowd psychology based on the activity and movement of Maravai Lifesciences' stock price.
Maravai Lifesciences Implied Volatility | 2.19 |
Maravai Lifesciences' implied volatility exposes the market's sentiment of Maravai Lifesciences Holdings stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Maravai Lifesciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Maravai Lifesciences stock will not fluctuate a lot when Maravai Lifesciences' options are near their expiration.
The Simple Moving Average forecasted value of Maravai Lifesciences Holdings on the next trading day is expected to be 3.26 with a mean absolute deviation of 0.11 and the sum of the absolute errors of 6.45. Maravai Lifesciences after-hype prediction price | USD 3.25 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Maravai Lifesciences to cross-verify your projections. Prediction based on Rule 16 of the current Maravai contract
Based on the Rule 16, the options market is currently suggesting that Maravai Lifesciences Holdings will have an average daily up or down price movement of about 0.14% per day over the life of the 2026-03-20 option contract. With Maravai Lifesciences trading at USD 3.26, that is roughly USD 0.004462 . If you think that the market is fully incorporating Maravai Lifesciences' daily price movement you should consider acquiring Maravai Lifesciences Holdings options at the current volatility level of 2.19%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Maravai Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Maravai Lifesciences' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Maravai Lifesciences' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Maravai Lifesciences stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Maravai Lifesciences' open interest, investors have to compare it to Maravai Lifesciences' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Maravai Lifesciences is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Maravai. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Maravai Lifesciences Additional Predictive Modules
Most predictive techniques to examine Maravai price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Maravai using various technical indicators. When you analyze Maravai charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Maravai Lifesciences Simple Moving Average Price Forecast For the 5th of February
Given 90 days horizon, the Simple Moving Average forecasted value of Maravai Lifesciences Holdings on the next trading day is expected to be 3.26 with a mean absolute deviation of 0.11, mean absolute percentage error of 0.02, and the sum of the absolute errors of 6.45.Please note that although there have been many attempts to predict Maravai Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Maravai Lifesciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Maravai Lifesciences Stock Forecast Pattern
| Backtest Maravai Lifesciences | Maravai Lifesciences Price Prediction | Research Analysis |
Maravai Lifesciences Forecasted Value
In the context of forecasting Maravai Lifesciences' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Maravai Lifesciences' downside and upside margins for the forecasting period are 0.03 and 7.54, respectively. We have considered Maravai Lifesciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Maravai Lifesciences stock data series using in forecasting. Note that when a statistical model is used to represent Maravai Lifesciences stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 110.6215 |
| Bias | Arithmetic mean of the errors | -0.0097 |
| MAD | Mean absolute deviation | 0.1094 |
| MAPE | Mean absolute percentage error | 0.0308 |
| SAE | Sum of the absolute errors | 6.455 |
Predictive Modules for Maravai Lifesciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Maravai Lifesciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Maravai Lifesciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Maravai Lifesciences After-Hype Price Density Analysis
As far as predicting the price of Maravai Lifesciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Maravai Lifesciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Maravai Lifesciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Maravai Lifesciences Estimiated After-Hype Price Volatility
In the context of predicting Maravai Lifesciences' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Maravai Lifesciences' historical news coverage. Maravai Lifesciences' after-hype downside and upside margins for the prediction period are 0.16 and 7.49, respectively. We have considered Maravai Lifesciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Maravai Lifesciences is risky at this time. Analysis and calculation of next after-hype price of Maravai Lifesciences is based on 3 months time horizon.
Maravai Lifesciences Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Maravai Lifesciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Maravai Lifesciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Maravai Lifesciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.29 | 4.28 | 0.01 | 0.50 | 8 Events / Month | 4 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
3.26 | 3.25 | 0.31 |
|
Maravai Lifesciences Hype Timeline
Maravai Lifesciences is now traded for 3.26. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.5. Maravai is anticipated to decline in value after the next headline, with the price expected to drop to 3.25. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.31%, whereas the daily expected return is now at 0.29%. The volatility of related hype on Maravai Lifesciences is about 246.26%, with the expected price after the next announcement by competition of 2.76. About 12.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.99. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Maravai Lifesciences recorded a loss per share of 0.84. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 8 days. Check out Historical Fundamental Analysis of Maravai Lifesciences to cross-verify your projections.Maravai Lifesciences Related Hype Analysis
Having access to credible news sources related to Maravai Lifesciences' direct competition is more important than ever and may enhance your ability to predict Maravai Lifesciences' future price movements. Getting to know how Maravai Lifesciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Maravai Lifesciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GILD | Gilead Sciences | (0.69) | 7 per month | 1.26 | 0.16 | 3.01 | (2.41) | 6.70 | |
| SNY | Sanofi ADR | (0.12) | 5 per month | 0.00 | (0.11) | 1.87 | (2.19) | 5.92 | |
| AMGN | Amgen Inc | (6.78) | 6 per month | 1.25 | 0.11 | 3.47 | (2.59) | 11.18 | |
| MRK | Merck Company | 0.05 | 6 per month | 1.09 | 0.24 | 3.59 | (1.98) | 8.09 | |
| NVO | Novo Nordisk AS | (1.15) | 6 per month | 3.26 | (0.01) | 5.80 | (4.02) | 13.19 |
Other Forecasting Options for Maravai Lifesciences
For every potential investor in Maravai, whether a beginner or expert, Maravai Lifesciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Maravai Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Maravai. Basic forecasting techniques help filter out the noise by identifying Maravai Lifesciences' price trends.Maravai Lifesciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maravai Lifesciences stock to make a market-neutral strategy. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Maravai Lifesciences Market Strength Events
Market strength indicators help investors to evaluate how Maravai Lifesciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Maravai Lifesciences shares will generate the highest return on investment. By undertsting and applying Maravai Lifesciences stock market strength indicators, traders can identify Maravai Lifesciences Holdings entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 3.26 | |||
| Day Typical Price | 3.26 | |||
| Price Action Indicator | (0.06) | |||
| Period Momentum Indicator | (0.11) | |||
| Relative Strength Index | 45.92 |
Maravai Lifesciences Risk Indicators
The analysis of Maravai Lifesciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Maravai Lifesciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting maravai stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.96 | |||
| Semi Deviation | 3.54 | |||
| Standard Deviation | 4.18 | |||
| Variance | 17.46 | |||
| Downside Variance | 15.75 | |||
| Semi Variance | 12.51 | |||
| Expected Short fall | (3.55) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Maravai Lifesciences
The number of cover stories for Maravai Lifesciences depends on current market conditions and Maravai Lifesciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Maravai Lifesciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Maravai Lifesciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Maravai Lifesciences Short Properties
Maravai Lifesciences' future price predictability will typically decrease when Maravai Lifesciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Maravai Lifesciences Holdings often depends not only on the future outlook of the potential Maravai Lifesciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Maravai Lifesciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 137.9 M | |
| Cash And Short Term Investments | 322.4 M |
Check out Historical Fundamental Analysis of Maravai Lifesciences to cross-verify your projections. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is there potential for Life Sciences Tools & Services market expansion? Will Maravai introduce new products? Factors like these will boost the valuation of Maravai Lifesciences. Expected growth trajectory for Maravai significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Maravai Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.33) | Earnings Share (0.84) | Revenue Per Share | Quarterly Revenue Growth (0.40) | Return On Assets |
Understanding Maravai Lifesciences requires distinguishing between market price and book value, where the latter reflects Maravai's accounting equity. The concept of intrinsic value - what Maravai Lifesciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Maravai Lifesciences' price substantially above or below its fundamental value.
Understanding that Maravai Lifesciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Maravai Lifesciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Maravai Lifesciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.